Usana Health Sciences
USNA
164 hedge funds and large institutions have $336M invested in Usana Health Sciences in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 69 increasing their positions, 46 reducing their positions, and 27 closing their positions.
2,744% more call options, than puts
Call options by funds: $256K | Put options by funds: $9K
50% more repeat investments, than reductions
Existing positions increased: 69 | Existing positions reduced: 46
16% more capital invested
Capital invested by funds: $290M → $336M (+$46.2M)
11% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 27
2.27% more ownership
Funds ownership: 56.86% → 59.13% (+2.3%)
1% more funds holding
Funds holding: 162 → 164 (+2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$4.6M |
| 2 |
Pzena Investment Management
New York
|
+$2.93M |
| 3 |
Goldman Sachs
New York
|
+$2.56M |
| 4 |
Renaissance Technologies
New York
|
+$1.98M |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$1.94M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$10.3M |
| 2 |
D.E. Shaw & Co
New York
|
-$2.02M |
| 3 |
BlackRock
New York
|
-$1.29M |
| 4 |
Man Group
London,
United Kingdom
|
-$1.29M |
| 5 |
HF
HRT Financial
New York
|
-$1.27M |
USNA Hedge Fund Activity: Q2 2025 in Review
164 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2025, worth a combined $336M — up 16% from $290M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new USNA positions and 27 closed out — a net gain of 3 holders — while 69 added to existing stakes and 46 trimmed.
The largest buyer was Jacobs Levy Equity Management, adding an estimated $4.6M. The largest seller was Vanguard Group, cutting an estimated $10.3M.
- 164 institutional investors held Usana Health Sciences (USNA) as of Q2 2025, up from 162 in Q1 2025.
- Funds reported $336M of Usana Health Sciences stock for Q2 2025, up 16% quarter-over-quarter.
- 30 funds opened new Usana Health Sciences positions in Q2 2025 and 27 closed out, a net change of +3 holders.
- The largest Usana Health Sciences buyer in Q2 2025 was Jacobs Levy Equity Management, an estimated $4.6M added.
- The largest Usana Health Sciences seller in Q2 2025 was Vanguard Group, an estimated $10.3M sold.
Based on aggregated 13F filings for Q2 2025.